[{"id":"a3d4b8ea-48dd-4cdc-ae07-718e68da89e4","acronym":"","url":"https://clinicaltrials.gov/study/NCT02986919","created_at":"2021-01-18T14:41:37.538Z","updated_at":"2024-07-02T16:37:07.019Z","phase":"Phase 2","brief_title":"Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors","source_id_and_acronym":"NCT02986919","lead_sponsor":"University of Texas Southwestern Medical Center","biomarkers":" BCL2L11","pipe":"","alterations":" ","tags":["BCL2L11"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pelabresib (DAK539)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 05/05/2017","start_date":" 05/05/2017","primary_txt":" Primary completion: 05/17/2018","primary_completion_date":" 05/17/2018","study_txt":" Completion: 05/17/2018","study_completion_date":" 05/17/2018","last_update_posted":"2018-09-11"}]